FP 7 UK Technology Strategy Board Driving Innovation Horizon 2020 – The Health Challenge Manchester – 12 th November 2013 Octavio Pernas - FP 7 UK National Contact Point for Health
FP 7 UK Agenda • • Facts and figures Policy overview What’s on the Horizon 2020 The Health Challenge Technology Strategy Board Driving Innovation
FP 7 UK Agenda • • Facts and figures Policy overview What’s on the Horizon 2020 The Health Challenge Technology Strategy Board Driving Innovation
Technology Strategy Board FP 7 UK Driving Innovation Facts and figures FP 7 Health Theme Funding, 2007 - 2013 Year Total Funding Projects Funded Topics SME Targeted 2007 € 641 million 153 87 0% 2008 € 577 million 172 87 0% 2009 € 593 million 108 71 0% 2010 € 628 million 131 72 0% 2011 € 657 million 124 51 20% 2012 € 657 million 140 37 53% 2013 € 819 million 143 37 55%
FP 7 UK Technology Strategy Board Driving Innovation Facts and figures FP 7 2013 Health Call FP 7 -HEALTH-2013 -Innovation-1 (35 topics, € 679 million) • Opening: 10 Jul. 2012 • stage 1 proposals, deadline: 3 Oct. 2012 – 1281 proposals evaluated • evaluation: => 370 proposals invited to submit full proposal (6 Dec. ) • stage 2 proposals, deadline: 6 Feb. 2013 => 364 proposals submitted • 128 proposals short-listed for funding (18 Apr. ) • Validation and negotiation!
Technology Strategy Board FP 7 UK Driving Innovation Facts and figures FP 7 Health Theme – Participants 0 200 400 600 800 1000 1200 1400 1600 United Kingdom Germany France Netherlands Italy Sweden All participants SME Spain Switzerland Belgium UK has highest level of participation in successful health projects Denmark http: //ec. europa. eu/research/sme-techweb/pdf/sme_participaton_in_fp 7_june_2013. pdf#view=fit&pagemode=none
Technology Strategy Board FP 7 UK Driving Innovation Facts and figures FP 7 Health Theme – EC contribution (€ M) 0 100 200 300 400 500 600 700 800 United Kingdom Germany France Netherlands Italy Sweden All participants SME Spain Switzerland Belgium Denmark UK organisations have secured > € 670 million of EU funding for Health research http: //ec. europa. eu/research/sme-techweb/pdf/sme_participaton_in_fp 7_june_2013. pdf#view=fit&pagemode=none
FP 7 UK Agenda • • Facts and figures Policy overview What’s on the Horizon 2020 The Health Challenge Technology Strategy Board Driving Innovation
FP 7 UK Technology Strategy Board Driving Innovation Policy overview Policy context • Historical milestones in the European Union • European Research Policy - Development and evolution of European Research and Technological Framework Programmes • Lisbon Strategy / European Research Area (ERA) • Europe 2020 / 7 Flagships Initiatives / Innovation Union • Multiannual Financial Framework (MFF, 2014 -2020) • Adoption process of Horizon 2020
Technology Strategy Board FP 7 UK Driving Innovation Policy overview Policy context Financial instrument implementing the Innovation Union (Europe 2020 flagship initiative) What is Horizon 2020?
FP 7 UK Agenda • • Facts and figures Policy overview What’s on the Horizon 2020 The Health Challenge Technology Strategy Board Driving Innovation
FP 7 UK Technology Strategy Board Driving Innovation What’s on the Horizon 2020: What is it? • 70. 20 billion euro research and innovation funding programme (2014 -2020) • New framework programme bringing together three separate programmes/initiatives (FP, EIT, CIP) • Continuation of investment in frontier research • More support for innovation activities – focus on business opportunities • Simplification (e. g. reduction of average time to grant by 100 days)
FP 7 UK Technology Strategy Board Driving Innovation What’s on the Horizon 2020: What’s new? • Single set of rules for participation, coherent with other new EU Programmes • One project – one funding rate - Eligible costs: direct + indirect (flat rate, 25% of direct costs) - 100% rate for research projects; - 70 % rate for activities closer to market; • Simple evaluation criteria: Excellence, Impact, Implementation • New funding schemes: pre-commercial procurement, prizes, loan and equity instruments, etc.
FP 7 UK What’s on the Horizon 2020: Three priorities 1. Excellent Science 2. Competitive Industries 3. Better Society Technology Strategy Board Driving Innovation
FP 7 UK Technology Strategy Board Driving Innovation What’s on the Horizon 2020: Excellent Science (€Bn) European Research Council (ERC) Supporting world leading scientist in blue sky research 11. 93 Future and Emerging Technologies (FET) Collaborative research to open new fields of innovation 2. 46 Marie Skłodowska-Curie actions (MSCA) Opportunities for training and career development 5. 62 Research infrastructures (including e-infrastructure) Ensuring access to world-class facilities 2. 27
FP 7 UK Technology Strategy Board Driving Innovation What’s on the Horizon 2020: Competitive Industries (€Bn) Leadership in enabling and industrial technologies (LEIT) ICT (45 %), nanotechnologies (22 %), biotechnology (3 %), etc 12. 35 Access to risk finance Leveraging private finance and venture capital for research and innovation 2. 59 Innovation in SMEs Fostering all forms of innovation in all types of SMEs 0. 6 complemented by c. 20% of societal challenges and industrial leadership and ‘access to risk finance’ with strong SME focus
Technology Strategy Board FP 7 UK Driving Innovation Horizon 2020: SME instrument Concept & Feasibility Assessment Demonstration Market Replication R&D Commercialisation SME window EU financial facilities Idea to concept, risk assessment, technological & commercial feasibility IDEA Demonstration, prototyping, testing , market replication, scaling up, miniaturisation, research continued support throughout the project Quality label for successful projects, access to risk finance, indirect support MARKET
FP 7 UK Technology Strategy Board Driving Innovation What’s on the Horizon 2020: Better Society (€Bn) Health, demographic change and wellbeing 6. 81 Food security, sustainable agriculture & the bioeconomy 3. 51 Secure, clean and efficient energy 5. 40 Smart, green and integrated transport 5. 78 Climate action, resource efficiency and raw materials 2. 81 Europe in a changing world - inclusive, innovative and reflective societies 1. 20 Secure societies – protecting freedom and security of Europe and its citizen 1. 50
Technology Strategy Board FP 7 UK Driving Innovation 3 Pillar Structure Excellent Science European Research Council (ERC) Future & Emerging Technologies (FET) Marie Skłodowska. Curie actions Research Infrastructures Spreading Excellence and Widening Participation Industrial Leadership Societal Challenges Health, demographic change and wellbeing Leadership in Enabling and Industrial Technologies Food security, sustainable agriculture, forestry, marine, maritime, inland water and bioeconomy Secure, clean and efficient energy Smart, green and integrated transport Access to Risk Finance Innovation Climate action, environment, resource efficiency and raw materials Inclusive, innovative and reflective societies in SMEs Science with and for Society Secure societies – protecting freedom and security of Europe and its citizens EIT JRC
FP 7 UK Agenda • • Facts and figures Policy overview What’s on the Horizon 2020 The Health Challenge Technology Strategy Board Driving Innovation
FP 7 UK Technology Strategy Board Driving Innovation The Health Challenge Health, demographic change and wellbeing challenge (SC 1) • Less prescription – what to do, but not how to do it • Strengthening competitiveness of EU industries - development of new market opportunities • Multidisciplinary approach - fostering cooperation between academic and industrial sectors • Also implemented by the Innovative Medicines Initiative (IMI) 2; European & Developing Countries Clinical Trials Partnership (EDCTP); Ambient Assisted Living (AAL) 2
Technology Strategy Board FP 7 UK Driving Innovation The Health Challenge SC 1 – Draft work programme • Work programmes with a 2 year-duration! • 15 topics in the ‘co-ordination activities’ call (7 ERA-NET) • 36 topics in the ‘personalising health and care’ focus area call • Objectives: • Create opportunities for real breakthrough research • Translation of findings into the clinic • Reduce health inequalities • Promote active and healthy ageing
FP 7 UK Technology Strategy Board Driving Innovation The Health Challenge SC 1 – ‘Personalising health and care’ 1. Understanding health, ageing and disease – 3 topics 2. Effective health promotion, disease prevention, preparedness and screening – 6 topics 3. Improving diagnosis – 3 topics 4. Innovative treatments and technologies – 6 topics 5. Advancing active and healthy ageing – 4 topics 6. Integrated, sustainable, citizen-centred care – 8 topics 7. Improving health information, data exploitation and providing an evidence base for health policies and regulation – 6 topics
FP 7 UK Technology Strategy Board Driving Innovation The Health Challenge SC 1 – Understanding the needs PHC 10 - 2014) Development of new diagnostic tools and technologies: in vitro devices, assays and platforms Specific challenge: • The development of new diagnostics (more sensitive, robust and selective) for improved clinical practice demands the translation of multidisciplinary scientific and technological knowledge from diverse fields into clinical applications. (…) • A wide range of multidisciplinary competencies need to be brought together to develop and bring new diagnostics to the patient. This is also a field where many small European companies are active. Scope: • Proposals will focus on the development of innovative in vitro diagnostic tools and technologies (not novel applications of existing ones) (…) Expected impact: • New in vitro diagnostic tools and methods providing more accurate, more reliable and earlier disease diagnosis (…) Type of action: Research and Innovation action
FP 7 UK The Health Challenge Participant portal • Work Programme • Call Fiche • Annexes • Guide for Applicants • Financial guide Read all relevant documents! http: //ec. europa. eu/research/participants/portal/page/call_FP 7#wlp_call_FP 7 Technology Strategy Board Driving Innovation
Technology Strategy Board FP 7 UK Driving Innovation The Health Challenge SC 1 – ‘Personalising health and care’ AREA BUDGET TYPE OF (€M) ACTION TITLE PHC 1 -2014 Understanding health, ageing and disease CODE Understanding health, ageing and disease: determinants, risk factors and pathways 4– 6 R&I Action PHC 2 -2015 Understanding diseases: systems medicine 4– 6 R&I Action Understanding common mechanisms of PHC 3 -2015 diseases and their relevance in comorbidities 4– 6 R&I Action
Technology Strategy Board FP 7 UK Driving Innovation The Health Challenge SC 1 – ‘Personalising health and care’ CODE TITLE BUDGET (€M) TYPE OF ACTION PHC 4 -2015 AREA Health promotion and disease prevention: improved intersector co-operation for environment and health based interventions 4– 6 R&I Action PHC 5 -2014 4– 6 PHC 6 -2014 Effective health promotion, disease prevention, preparedness and screening Health promotion and disease prevention: translating ‘omics’ into stratified approaches Evaluating existing screening and prevention Programmes 2– 3 PHC 7 -2014 Improving the control of infectious epidemics and foodborne outbreaks through rapid identification of pathogens (see also SC 2) 15 – 20 R&I Action PHC 8 -2014 Vaccine development for poverty-related and neglected infectious diseases: Tuberculosis 15 – 20 R&I Action PHC 9 -2015 Vaccine development for poverty-related and neglected infectious diseases – HIV/AIDS 15 – 20 R&I Action
Technology Strategy Board FP 7 UK Driving Innovation The Health Challenge SC 1 – ‘Personalising health and care’ AREA CODE PHC 10 -2014 Improving diagnosis TITLE Development of new diagnostic tools and technologies: in vitro devices, assays and platforms BUDGET (€M) TYPE OF ACTION 4– 6 R&I Action PHC 11 -2015 Development of new diagnostic tools and technologies: in vivo medical imaging technologies 4– 6 PHC 12 -2014 and 2015 Clinical validation of biomarkers 2– 5 R&I Action SME instrument
Technology Strategy Board FP 7 UK Driving Innovation The Health Challenge SC 1 – ‘Personalising health and care’ AREA CODE TITLE PHC 13 -2014 New therapies for chronic non-communicable diseases PHC 14 -2015 New therapies for rare diseases PHC 15 -2014 and 2015 Clinical research on regenerative medicine BUDGET (€M) TYPE OF ACTION 4– 6 R&I Action Innovative treatments and technologies PHC 16 -2015 Tools and technologies for advanced therapies PHC 17 -2014 Comparing the effectiveness of existing healthcare interventions in the elderly 4– 6 R&I Action PHC 18 -2015 Establishing effectiveness of health care interventions in the paediatric population 4– 6 R&I Action
Technology Strategy Board FP 7 UK Driving Innovation The Health Challenge SC 1 – ‘Personalising health and care’ AREA CODE PHC 19 -2014 Advancing active and healthy ageing TITLE Advancing active and healthy ageing with ICT: Service robotics within assisted living environments Advancing active and healthy ageing with PHC 20 -2014 ICT: ICT solutions for independent living with cognitive impairment PHC 21 -2015 Advancing active and healthy ageing with ICT: Early risk detection and intervention PHC 22 -2015 Promoting mental wellbeing: in the ageing population BUDGET TYPE OF (€M) ACTION 3– 4 R&I Action 2– 3 Inn Action 3– 4 R&I Action 4– 6 R&I Action
Technology Strategy Board FP 7 UK Driving Innovation The Health Challenge SC 1 – ‘Personalising health and care’ AREA CODE PHC 23 -2014 Integrated, sustainable, citizen-centred care (I) PHC 24 -2015 TITLE Developing and comparing new models for safe and efficient, prevention oriented, health and care systems Piloting personalised medicine in health and care systems PHC 25 -2015 Advanced ICT systems and services for Integrated Care PHC 26 -2014 Self-management of health and disease: citizen engagement and m. Health BUDGET TYPE OF (€M) ACTION 4– 6 R&I Action 12 – 15 R&I Action 3– 5 R&I Action
Technology Strategy Board FP 7 UK Driving Innovation The Health Challenge SC 1 – ‘Personalising health and care’ Integrated, sustainable, citizen-centred care (II) BUDGET (€M) TYPE OF ACTION Self-management of health and disease and PHC 27 -2015 patient empowerment supported by ICT AREA 3– 5 Precommercial procurement Self-management of health and disease and decision support systems based on predictive PHC 28 -2015 computer modelling used by the patient him or herself 3– 5 R&I Action CODE TITLE PHC 29 -2015 Public procurement of innovative e. Health services PHC 30 -2015 e. Health Sectoral Inducement Prize 4– 5 2 Public procurement of innovative solutions Inducement prize
Technology Strategy Board FP 7 UK Driving Innovation The Health Challenge SC 1 – ‘Personalising health and care’ AREA CODE TITLE PHC 31 -2015 PHC 32 -2014 Improving health information, data exploitation and providing an evidence base for health policies and regulation Digital representation of health data to improve disease diagnosis and treatment Foresight for health policy development and regulation PHC 33 -2014 Advancing bioinformatics to meet biomedical and clinical needs PHC 34 -2015 New approaches to improve predictive human safety testing PHC 35 -2014 e. Health interoperability PHC 36 -2015 Inducement prize – topic TBC BUDGET (€M) TYPE OF ACTION 3– 5 R&I Action 2– 3 R&I Action 10 – 15 R&I Action 1 CSA TBC Inducement prize
Technology Strategy Board FP 7 UK Driving Innovation The Health Challenge SC 1 – ‘Coordination activities’ AREA CODE HC 01 -2014 Co-ordination activities (I) TITLE Innovation Partnership: Support for the European Innovation Partnership on Active and Healthy Ageing Joint Programming: Coordination Action for the HC 02 -2014 Joint Programming Initiative (JPI) "More Years, Better Lives - the Challenges and Opportunities of Demographic Change" HC 03 -2015 Support for the European Reference Networks: Efficient network modelling and validation HC 04 -2014 Support for international infectious disease preparedness research BUDGET (€M) TYPE OF ACTION 1– 2 CSA 0. 5 CSA 2– 3 CSA
Technology Strategy Board FP 7 UK Driving Innovation The Health Challenge SC 1 – ‘Coordination activities’ AREA CODE TITLE HC 05 -2014 Global Alliance for Chronic Diseases: prevention and treatment of type 2 diabetes BUDGET TYPE OF (€M) ACTION 1– 3 R&I Action HC 014 -2014 New approaches to bridge the divide in European health research and innovation 1 CSA HC 015 -2014 Mobilisation and mutual learning action plan in the area of societal challenge 1 1 CSA HC 06 -2015 Global Alliance for Chronic Diseases: subject to be confirmed Coordination activities (II) Plus 7 ERA-Net topics (funding bodies, coordination of agendas)
FP 7 UK Technology Strategy Board Driving Innovation The Health Challenge Next steps • Draft Work Programme under discussion • Health Information Day: 22 nd November 2013, Brussels * • Publication of the call for proposals: 11 th December 2013 (indicative date) * http: //ec. europa. eu/research/health/horizon-2020 -health-open-info-days_en. html
FP 7 UK Technology Strategy Board Driving Innovation Further information • European Commission – Horizon 2020: http: //ec. europa. eu/research/horizon 2020/index_en. cfm • Participant portal: http: //ec. europa. eu/research/participants/portal/page/home • Fit for Health: http: //www. fitforhealth. eu/ • Healthcompetence: http: //www. healthcompetence. eu/ • _Connect (NCP network): https: //connect. innovateuk. org/web/fp 7 -uk-health
FP 7 UK Technology Strategy Board Driving Innovation FP 7 Health National Contact Point: Octavio Pernas Website: https: //connect. innovateuk. org/web/fp 7 -uk-health E mail: octavio. pernas@tsb. gov. uk Phone: 01302 322633 Mobile: 07775 584028 Twitter: @FP 7_Health_NCP Alternative: Alex Harris Alex. Harris@headoffice. mrc. co. uk 02073 952214
Скачать презентацию FP 7 UK Technology Strategy Board Driving Innovation
cde59604da58117145db69bf9018b325.ppt